{"id":"W2171046634","doi":"10.1158/1078-0432.ccr-08-0761","title":"Phase I Study of Cediranib in Combination with Oxaliplatin and Infusional 5-Fluorouracil in Patients with Advanced Colorectal Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Sanofi; AstraZeneca","keywords":"Medicine; Oxaliplatin; Pharmacokinetics; Tolerability; FOLFOX; Internal medicine; Colorectal cancer; Fluorouracil; Regimen; Dosing; Pharmacology; Oncology; Phases of clinical research; Gastroenterology; Toxicity; Chemotherapy; Cancer; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001369161,0.001459899,0.002559929,0.0005161697,0.0004964311,0.0009343547,0.001011783,0.001008992,0.001683594],"category_scores_gemma":[0.001091304,0.0007076589,0.0009970507,0.0005366492,0.0009728604,0.0005780479,0.0003155157,0.003176273,0.0005643952],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001085408,"about_ca_system_score_gemma":0.001718184,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001089919,"about_ca_topic_score_gemma":0.002570835,"domain_scores_codex":[0.9993752,0.0003227967,0.00003603983,0.00009029271,0.00007952475,0.00009605654],"domain_scores_gemma":[0.9991641,0.0001327311,0.0001688174,0.00006324236,0.00005523119,0.000415883],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5703619,0.143819,0.01882187,0.001389585,0.002908213,0.0008741978,0.0006809396,0.005798058,0.1019864,0.0003497644,0.004689516,0.1483206],"study_design_scores_gemma":[0.3943685,0.5779862,0.0157575,0.00004362851,0.0005520149,0.0005383984,0.00005745907,0.002065313,0.005641601,0.00007874618,0.002877394,0.00003325466],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930581,0.002775259,0.0006788993,0.0003849358,0.0001329702,0.00136073,0.000351841,0.00007117521,0.001186081],"genre_scores_gemma":[0.9929028,0.001628467,0.001729457,0.0004415525,0.0001688775,0.001002892,0.001106282,0.00001889698,0.001000788],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002559929,"threshold_uncertainty_score":0.007875144,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08583454801042077,"score_gpt":0.485112590518211,"score_spread":0.3992780425077903,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}